Hemangio Journal

Liver involvement remains the strongest negative prognostic indicator, but pulmonary and muscular metastases showed no significant impact on survival.

Published on: February 25, 2026

Hemangiosarcoma cells use lactate to activate genes that let them synthesize asparagine from glutamine.

Published on: February 16, 2026

This study provides the first controlled evidence that trained dogs can detect a distinct odor signature in the blood serum of dogs with hemangiosarcoma

Published on: December 28, 2025

Circulating microRNA panel could diagnose canine splenic HSA with 80% sensitivity.

Published on: December 7, 2025

This research analyzed data from the Golden Retriever Lifetime Study. Its rigorous design confirms the negative findings are due to data limitations, not a flawed methodology.

Published on: November 2, 2025

The finding opens a new avenue for research by identifying a previously overlooked pathway in canine cancer.

Published on: October 22, 2025

Data from 12 dogs showed stable cardiac troponin levels and a reduction in adverse events across treatment.

Published on: October 19, 2025

A single dose of an oncolytic virus, combined with standard care, led to a survival of over seven years for a dog with an aggressive bone hemangiosarcoma diagnosis

Published on: October 2, 2025

The study evaluated a new therapeutic approach combining standard chemotherapy with a conjugate vaccine technology called “iBoost”

Published on: September 25, 2025

Thrombosis risk outweighed infection risk in 104 dogs after splenectomy for benign conditions.

Published on: August 7, 2025

A longitudinal cohort study of Golden Retrievers investigated demographic, lifestyle, and clinical factors associated with the diagnosis.

Published on: July 30, 2025

A breakthrough blood test could detect early-stage hemangiosarcoma and 4 other canine cancers with 60-98% accuracy.

Published on: June 18, 2025